litlas
ログインアカウント作成

William D. Tap

1995–2025 年に発表

163
論文数
23,412
被引用数
75
h 指数
152
i10 指数

被引用数

William D. Tap の年別被引用数1976 年: 被引用 1 件1977 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 11 件1997 年: 被引用 6 件1998 年: 被引用 4 件1999 年: 被引用 2 件2000 年: 被引用 2 件2001 年: 被引用 5 件2002 年: 被引用 2 件2004 年: 被引用 3 件2006 年: 被引用 2 件2007 年: 被引用 1 件2008 年: 被引用 3 件2009 年: 被引用 11 件2010 年: 被引用 14 件2011 年: 被引用 15 件2012 年: 被引用 32 件2013 年: 被引用 41 件2014 年: 被引用 47 件2015 年: 被引用 68 件2016 年: 被引用 98 件2017 年: 被引用 170 件2018 年: 被引用 144 件2019 年: 被引用 758 件2020 年: 被引用 1,229 件2021 年: 被引用 1,327 件2022 年: 被引用 1,163 件2023 年: 被引用 904 件2024 年: 被引用 1,479 件2025 年: 被引用 690 件2026 年: 被引用 14 件1978〜1994 年は被引用が無いため表示していません2003 年は被引用が無いため表示していません2005 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,944 件、この内訳の 27.2%中国: 引用元論文 1,665 件、この内訳の 15.4%イギリス: 引用元論文 593 件、この内訳の 5.5%イタリア: 引用元論文 558 件、この内訳の 5.1%ドイツ: 引用元論文 519 件、この内訳の 4.8%フランス: 引用元論文 475 件、この内訳の 4.4%カナダ: 引用元論文 374 件、この内訳の 3.4%オランダ: 引用元論文 372 件、この内訳の 3.4%スペイン: 引用元論文 335 件、この内訳の 3.1%日本: 引用元論文 302 件、この内訳の 2.8%オーストラリア: 引用元論文 249 件、この内訳の 2.3%スイス: 引用元論文 220 件、この内訳の 2%
0%27.2%その他 20.6%

機関

分野

  • Medicine70.3%
  • Biochemistry, Genetics and Molecular Biology19.4%
  • Immunology and Microbiology6.3%
  • Neuroscience1%
  • Engineering0.6%
  • Computer Science0.5%
  • その他1.9%

トピック

  • Cancer Immunotherapy and Biomarkers7.9%
  • Sarcoma Diagnosis and Treatment7.5%
  • Cancer Genomics and Diagnostics3.6%
  • CAR-T cell therapy research3.4%
  • Immunotherapy and Immune Responses3.1%
  • Ferroptosis and cancer prognosis2.3%
  • その他72.2%

共著者

全論文

検索で開く
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    著者: Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Matthew D. Hellmann, Ronglai Shen, Yelena Y. Janjigian, David Barron, Ahmet Zehir, Emmet Jordan, Antonio Omuro, Thomas Kaley, Sviatoslav M. Kendall, Robert J. Motzer, A. Ari Hakimi, Martin H. Voss, Paul Russo, Jonathan E. Rosenberg, Gopa Iyer, Bernard H. Bochner, Dean F. Bajorin, Hikmat Al‐Ahmadie, Jamie E. Chaft, Charles M. Rudin, Gregory J. Riely, Shrujal S. Baxi, Alan L. Ho, Richard J. Wong, David G. Pfister, Jedd D. Wolchok, Christopher A. Barker, Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 被引用: 4,358

  2. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Mark T.A. Donoghue, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. Iacobuzio–Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 被引用: 663

  3. Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

    著者: Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak, Mark Agulnik, Steven Attia, Jean‐Yves Blay, Irene Carrasco García, John A. Charlson, Edwin Choy, George D. Demetri, Mihaela Druta, Édouard Forcade, Kristen N. Ganjoo, John Glod, Vicki L. Keedy, Axel Le Cesne, David A. Liebner, Víctor Moreno, Seth M. Pollack, Scott M. Schuetze, Gary K. Schwartz, Sandra J. Strauss, William D. Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J. Wagner, Breelyn A. Wilky, Cheryl McAlpine, Laura Hudson, Jean‐Marc Navenot, Tianjiao Wang, Jane P. F. Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian Andrew Van Tine - The Lancet 2024 被引用: 263

  4. Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

    著者: Sandra P. D’Angelo, Michelle R. Mahoney, Brian Andrew Van Tine, James N. Atkins, Mohammed Milhem, Balkrishna Jahagirdar, Cristina R. Antonescu, Elise Horvath, William D. Tap, Gary K. Schwartz, Howard Streicher - The Lancet Oncology 2018 被引用: 748

  5. Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

    著者: William D. Tap, Hans Gelderblom, Emanuela Palmerini, Jayesh Desai, Sebastian Bauer, Jean‐Yves Blay, Thierry Alcindor, Kristen N. Ganjoo, Javier Martín‐Broto, Christopher W. Ryan, David M. Thomas, Charles Peterfy, John H. Healey, Michiel A. J. van de Sande, Heather L. Gelhorn, Dale E. Shuster, Qiang Wang, Antoine Yver, Henry H. Hsu, Paul Lin, Sandra Tong-Starksen, Silvia Stacchiotti, Andrew J. Wagner - The Lancet 2019 被引用: 474

  6. Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

    著者: William D. Tap, Zev A. Wainberg, Stephen P. Anthony, Prabha N. Ibrahim, Chao Zhang, John H. Healey, Bartosz Chmielowski, Arthur P. Staddon, Allen Lee Cohn, Geoffrey I. Shapiro, Vicki L. Keedy, Arun S. Singh, Igor Puzanov, Eunice L. Kwak, Andrew J. Wagner, Daniel D. Von Hoff, Glen J. Weiss, Ramesh K. Ramanathan, Jiazhong Zhang, Gaston Habets, Ying Zhang, Elizabeth A. Burton, Gary C. Visor, Laura Sanftner, Paul Severson, Hoa Nguyen, Marie J. Kim, Adhirai Marimuthu, Garson Tsang, Rafe Shellooe, C. M. Gee, Brian L. West, Peter Hirth, K. B. Nolop, Matt van de Rijn, Henry H. Hsu, Charles Peterfy, Paul Lin, Sandra Tong-Starksen, Gideon Bollag - New England Journal of Medicine 2015 被引用: 582

  7. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

    著者: Benjamin A. Nacev, Francisco Sánchez-Vega, Shaleigh Smith, Cristina R. Antonescu, Evan Rosenbaum, Hongyu Shi, Cerise Tang, Nicholas D. Socci, Satshil Rana, Rodrigo Gularte‐Mérida, Ahmet Zehir, Mrinal M. Gounder, Timothy G. Bowler, Anisha Luthra, Bhumika Jadeja, Azusa Okada, Jonathan A. Strong, Jake Stoller, Jason E. Chan, Ping Chi, Sandra P. D’Angelo, Mark A. Dickson, Ciara M. Kelly, Mary Louise Keohan, Sujana Movva, Katherine A. Thornton, Paul A. Meyers, Leonard H. Wexler, Emily K. Slotkin, Julia Glade Bender, Neerav Shukla, Martee L. Hensley, John H. Healey, Michael P. LaQuaglia, Kaled M. Alektiar, Aimeé M. Crago, Sam S. Yoon, Brian R. Untch, Sarah Chiang, Narasimhan P. Agaram, Meera Hameed, Michael F. Berger, David B. Solit, Nikolaus Schultz, Marc Ladanyi, Samuel Singer, William D. Tap - Nature Communications 2022 被引用: 211

  8. CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought

    著者: Mary E. Klein, Marta Kovatcheva, Lara E. Davis, William D. Tap, Andrew Koff - Cancer Cell 2018 被引用: 393

  9. Cancer Disparities and Health Equity: A Policy Statement From the American Society of Clinical Oncology

    著者: Manali I. Patel, Ana María López, William Blackstock, Katherine E. Reeder‐Hayes, E. Allyn Moushey, Jonathan Phillips, William D. Tap - Journal of Clinical Oncology 2020 被引用: 329

  10. Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma

    著者: Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant, Donna Bernstein, John Glod, Rosandra N. Kaplan, Stephan A. Grupp, William D. Tap, Karen Chagin, Gwendolyn K. Binder, Samik Basu, Daniel E. Lowther, Ruoxi Wang, Natalie Bath, Alex J. Tipping, Gareth Betts, Indu Ramachandran, Jean‐Marc Navenot, Hua Zhang, Daniel K. Wells, Erin Van Winkle, Gabor Kari, Trupti Trivedi, Tom Holdich, Lini Pandite, Rafael G. Amado, Crystal L. Mackall - Cancer Discovery 2018 被引用: 435

  11. Sorafenib for Advanced and Refractory Desmoid Tumors

    著者: Mrinal M. Gounder, Michelle R. Mahoney, Brian A. Van Tine, Vinod Ravi, Steven Attia, Hari A. Deshpande, Abha A. Gupta, Mohammed Milhem, Robert M. Conry, Sujana Movva, Michael J. Pishvaian, Richard F. Riedel, Tarek Sabagh, William D. Tap, Natally Horvat, Ethan Basch, Lawrence H. Schwartz, Robert G. Maki, Narasimhan P. Agaram, Robert A. Lefkowitz, Yousef Mazaheri, Rikiya Yamashita, John J. Wright, Amylou C. Dueck, Gary K. Schwartz - New England Journal of Medicine 2018 被引用: 449

  12. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

    著者: Mrinal M. Gounder, Narasimhan P. Agaram, Sally E. Trabucco, Victoria Robinson, Richard Ferraro, Sherri Z. Millis, Anita Krishnan, Jessica Lee, Steven Attia, Wassim Abida, Alexander Drilon, Ping Chi, Sandra P. D’ Angelo, Mark A. Dickson, Mary Lou Keohan, Ciara M. Kelly, Mark Agulnik, Sant P. Chawla, Edwin Choy, Rashmi Chugh, Christian F. Meyer, Parvathi A. Myer, Jessica L. Moore, Ross A. Okimoto, Raphael E. Pollock, Vinod Ravi, Arun S. Singh, Neeta Somaiah, Andrew J. Wagner, John H. Healey, Garrett M. Frampton, Jeffrey M. Venstrom, Jeffrey S. Ross, Marc Ladanyi, Samuel Singer, Murray F. Brennan, Gary K. Schwartz, Alexander J. Lazar, David M. Thomas, Robert G. Maki, William D. Tap, Siraj M. Ali, Dexter X. Jin - Nature Communications 2022 被引用: 193

  13. The epigenomics of sarcoma

    著者: Benjamin A. Nacev, Kevin B. Jones, Andrew M. Intlekofer, Jamie Yu, C. David Allis, William D. Tap, Marc Ladanyi, Torsten O. Nielsen - Nature reviews. Cancer 2020 被引用: 208

  14. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors

    著者: William Lee, Sewit Teckie, Thomas Wiesner, Leili Ran, Carlos Prieto‐Granada, Mingyan Lin, Sinan Zhu, Zhen Cao, Yupu Liang, Andrea Sboner, William D. Tap, Jonathan A. Fletcher, Kety Huberman, Li-Xuan Qin, Agnès Viale, Samuel Singer, Deyou Zheng, Michael F. Berger, Yu Chen, Cristina R. Antonescu, Ping Chi - Nature Genetics 2014 被引用: 633

  15. Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

    著者: Silvia Stacchiotti, Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée, Dario Callegaro, Paolo G. Casali, RuRu Chun-Ju Chiang, George D. Demetri, Elisabeth G. Demicco, Jayesh Desai, Mikael Eriksson, Hans Gelderblom, Suzanne George, Mrinal M. Gounder, Alessandro Gronchi, Abha A. Gupta, Rick L. Haas, Andrea Hayes‐Jardon, Peter Hohenberger, Kevin B. Jones, Robin L. Jones, Bernd Kasper, Akira Kawai, David G. Kirsch, Eugene S. Kleinerman, Axel Le Cesne, Jiwon Lim, María Dolores Chirlaque López, Roberta Maestro, Rafael Marcos‐Gragera, Javier Martín‐Broto, Tomohiro Matsuda, Olivier Mir, Shreyaskumar Patel, Chandrajit P. Raut, Albiruni R. Abdul Razak, Damon R. Reed, Piotr Rutkowski, Roberta Sanfilippo, Marta Sbaraglia, Inga‐Marie Schaefer, D. Strauß, Kirsten Sundby Hall, William D. Tap, David M. Thomas, Winette T.A. van der Graaf, Winan J. van Houdt, Otto Visser, Margaret von Mehren, Andrew J. Wagner, Breelyn A. Wilky, Young‐Joo Won, Christopher D.�M. Fletcher, Angelo Paolo Dei Tos, Annalisa Trama - Cancer 2021 被引用: 227

  16. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    著者: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. lacobuzio-Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 被引用: 69

  17. Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab

    著者: Ciara M. Kelly, Cristina R. Antonescu, Timothy G. Bowler, Rodrigo Ramella Munhoz, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Reena Dholakia, Hamza Ahmad, Matthew D. Biniakewitz, Mercedes M. Condy, Haley T. Phelan, Margaret K. Callahan, Phillip Wong, S. J. Singer, Charlotte E. Ariyan, Edmund K. Bartlett, Aimeé M. Crago, Sam S. Yoon, Sinchun Hwang, Joseph P. Erinjeri, Li‐Xuan Qin, William D. Tap, Sandra P. D’Angelo - JAMA Oncology 2020 被引用: 205

  18. Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas

    著者: William D. Tap, Andrew J. Wagner, Patrick Schöffski, Javier Martín‐Broto, Anders Krarup‐Hansen, Kristen N. Ganjoo, Chueh‐Chuan Yen, Albiruni R. Abdul Razak, Alexander I. Spira, Akira Kawai, Axel Le Cesne, Brian A. Van Tine, Yoichi Naito, Se Hoon Park, А. А. Феденко, Zsuzsanna Pápai, Victoria Soldatenkova, Ashwin Shahir, Gary Mo, Jennifer Wright, Robin L. Jones, for the ANNOUNCE Investigators - JAMA 2020 被引用: 301

  19. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

    著者: Michael C. Heinrich, Robin L. Jones, Margaret von Mehren, Patrick Schöffski, César Serrano, Yoon‐Koo Kang, Philippe A. Cassier, Olivier Mir, Ferry A.L.M. Eskens, William D. Tap, Piotr Rutkowski, Sant P. Chawla, Jonathan C. Trent, Meera Tugnait, Erica N Evans, Tamieka Lauz, Teresa Zhou, Maria Roche, Beni B. Wolf, Sebastian Bauer, Suzanne George - The Lancet Oncology 2020 被引用: 304

  20. Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

    著者: William D. Tap, Zsuzsanna Pápai, Brian A. Van Tine, Steven Attia, Kristen N. Ganjoo, Robin L. Jones, Scott M. Schuetze, Damon R. Reed, Sant P. Chawla, Richard F. Riedel, Anders Krarup‐Hansen, Maud Toulmonde, Isabelle Ray‐Coquard, Peter Hohenberger, Giovanni Grignani, Lee D. Cranmer, Scott H. Okuno, Mark Agulnik, William L. Read, Christopher W. Ryan, Thierry Alcindor, Xavier F Garcia del Muro, G. Thomas Budd, Hussein A. Tawbi, Tillman Pearce, Stew Kroll, Denise K. Reinke, Patrick Schöffski - The Lancet Oncology 2017 被引用: 306

  21. Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma

    著者: William D. Tap, Víctor M. Villalobos, Gregory M. Coté, Howard A. Burris, Filip Jankú, Olivier Mir, M. Beeram, Andrew J. Wagner, Liewen Jiang, Bin Wu, Sung Choe, Katharine Yen, Camelia Gliser, Bin Fan, Sam Agresta, Shuchi S. Pandya, Jonathan C. Trent - Journal of Clinical Oncology 2020 被引用: 156

  22. Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement

    著者: Edward S. Kim, Thomas S. Uldrick, Caroline Schenkel, Suanna S. Bruinooge, R. Donald Harvey, Allison Magnuson, Alexander I. Spira, James L. Wade, Mark Stewart, Diana Merino Vega, Julia A. Beaver, Andrea Denicoff, Gwynn Ison, S. Percy Ivy, Suzanne George, Raymond P. Perez, Patricia A. Spears, William D. Tap, Richard L. Schilsky - Clinical Cancer Research 2021 被引用: 111

  23. Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    著者: Merry Jennifer Markham, KERRI WACHTER, Neeraj Agarwal, Monica M. Bertagnolli, Susan M. Chang, William Dale, Catherine Diefenbach, Carlos Rodríguez‐Galindo, Daniel J. George, Timothy D. Gilligan, R. Donald Harvey, Melissa L. Johnson, Randall J. Kimple, Miriam A. Knoll, Noelle K. LoConte, Robert G. Maki, Jane Meisel, Jeffrey A. Meyerhardt, Nathan A. Pennell, Gabrielle B. Rocque, Michael S. Sabel, Richard L. Schilsky, Bryan J. Schneider, William D. Tap, Robert G. Uzzo, Shannon N. Westin - Journal of Clinical Oncology 2020 被引用: 169

  24. A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

    著者: Ciara M. Kelly, Li‐Xuan Qin, Karissa Whiting, Allison L. Richards, Viswatej Avutu, Jason E. Chan, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Sujana Movva, Benjamin A. Nacev, Evan Rosenbaum, Travis E. Adamson, Samuel Singer, Edmund K. Bartlett, Aimeé M. Crago, Sam S. Yoon, Sinchun Hwang, Joseph P. Erinjeri, Cristina R. Antonescu, William D. Tap, Sandra P. D’Angelo - Clinical Cancer Research 2023 被引用: 69